Purdue Pharma agreed to settle Oklahoma’s claims its illegal marketing of Oxycontin caused financial devastation to local communities, the first accord in a wave of lawsuits stemming from the U.S. opioid crisis, according to people familiar with the matter
Oklahoma claims three opioid makers, including Purdue Pharma, understated the risks of prescription painkillers and overstated their benefit.
Still, Purdue’s settlement could help set the terms for other jurisdictions and companies looking to resolve the opioid litigation. Oklahoma Atty. Gen. Mike Hunter has scheduled a news conference for Tuesday afternoon. His spokesman, Alex Gerszewski, declined to comment on the Purdue Pharma accord. The settlement will allow Stamford, Conn.-based Purdue to avoid filing for bankruptcy at least for now, according to the sources, who declined to speak publicly about the deal because they weren’t authorized to do so. Craig Landau, Purdue’s chief executive officer, confirmed in a March 8 interview with the Washington Post that “bankruptcy is an option” to deal with the wave of opioid suits that threaten the pharmaceutical company’s financial strength.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Former DEA official now working for Oxycontin maker Purdue PharmaEXCLUSIVE: A former senior DEA official who testified before Congress on the government's efforts to stop the opioid epidemic is now working for Oxycontin maker Purdue Pharma
Baca lebih lajut »
OxyContin-maker Purdue Pharma reaches opioid settlement with Oklahoma Attorney General: SourceOxyContin-maker Purdue Pharma has agreed to settle a lawsuit by the state of Oklahoma accusing it of helping igniting the nationwide opioid crisis, a person familiar with the matter confirmed to CNBC.
Baca lebih lajut »
OxyContin maker Purdue agrees to settle Oklahoma opioid case: sourcePurdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusin...
Baca lebih lajut »
Purdue Pharma to settle historic Oklahoma opioid lawsuitPurdue Pharma has agreed to settle a historic lawsuit brought by the Oklahoma attorney general who accused the OxyContin maker of aggressively marketing the opioid painkiller and fueling a drug epidemic that left thousands dead in the state, a source familiar with the case tells CNN.
Baca lebih lajut »
Purdue Pharma Reaches $270 Million Settlement With Oklahoma in Opioid Crisis CasePurdue Pharma and its owners, the Sackler family, have agreed to pay $270 million to resolve claims by the Oklahoma attorney general that the company helped fuel the opioid crisis.
Baca lebih lajut »
Sackler Family Actively Trying to Resolve Purdue Pharma LawsuitsMembers of the Sackler family who own OxyContin maker Purdue Pharmahave become more involved in settlement talks to resolve the company’s share of lawsuits accusing drug makers of helping spark the opioid crisis.
Baca lebih lajut »
Purdue Pharma, state of Oklahoma reach settlement in landmark opioid lawsuitAs the first agreement in the current wave of litigation against drug companies, the deal could influence future legal action over the cost of the opioid epidemic.
Baca lebih lajut »
Some Sacklers Suspend Charity Donations Amid Opioid LawsuitsCertain members of the Sackler family, which owns prescription opioid maker Purdue Pharma, are suspending new charitable donations around the world as some recipients of the family’s philanthropy reconsider ties.
Baca lebih lajut »
London Gallery Will Forgo Donation From Purdue Pharma’s Sackler FamilyBritain’s National Portrait Gallery won’t proceed with a $1.3 million pledge from a charitable organization overseen by some members of the Sackler family, owners of OxyContin maker Purdue Pharma.
Baca lebih lajut »